Manulife (Manufacturers Life Insurance)’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.19M Sell
42,536
-697
-2% -$44.8K ﹤0.01% 1384
2026
Q1
$2.44M Sell
43,233
-2,877
-6% -$187K ﹤0.01% 1421
2025
Q4
$3.7M Sell
46,110
-165,480
-78% -$11.1M ﹤0.01% 1292
2025
Q3
$10.3M Sell
211,590
-242,340
-53% -$15M 0.01% 846
2025
Q2
$33.9M Buy
453,930
+68,326
+18% +$4.52M 0.03% 471
2025
Q1
$24.5M Buy
385,604
+71,537
+23% +$4.87M 0.02% 554
2024
Q4
$24.5M Buy
314,067
+255,338
+435% +$20.5M 0.02% 576
2024
Q3
$4.72M Sell
58,729
-248,835
-81% -$20.1M ﹤0.01% 1237
2024
Q2
$25.4M Buy
307,564
+235,535
+327% +$20.7M 0.02% 532
2024
Q1
$6.15M Buy
72,029
+12,601
+21% +$989K 0.01% 1104
2023
Q4
$5.08M Sell
59,428
-1,563
-3% -$135K ﹤0.01% 1163
2023
Q3
$5.46M Buy
60,991
+4,960
+9% +$443K ﹤0.01% 1079
2023
Q2
$4.77M Sell
56,031
-1,623
-3% -$137K ﹤0.01% 1098
2023
Q1
$4.77M Sell
57,654
-1,708
-3% -$138K ﹤0.01% 1103
2022
Q4
$4.67M Sell
59,362
-796
-1% -$64K ﹤0.01% 1099
2022
Q3
$4.45M Sell
60,158
-1,462
-2% -$105K ﹤0.01% 1099
2022
Q2
$4.02M Sell
61,620
-852
-1% -$50.4K ﹤0.01% 1189
2022
Q1
$3.95M Sell
62,472
-19,903
-24% -$1.08M ﹤0.01% 1303
2021
Q4
$4.37M Sell
82,375
-1,135
-1% -$69.2K ﹤0.01% 1307
2021
Q3
$5.89M Buy
83,510
+493
+0.6% +$31.1K ﹤0.01% 1175
2021
Q2
$5.53M Sell
83,017
-184,416
-69% -$13M ﹤0.01% 1237
2021
Q1
$29.7M Buy
267,433
+37,048
+16% +$4.58M 0.03% 502
2020
Q4
$27.4M Sell
230,385
-6,406
-3% -$690K 0.03% 507
2020
Q3
$20.7M Buy
236,791
+40,179
+20% +$3.51M 0.02% 529
2020
Q2
$17.3M Buy
196,612
+93,420
+91% +$9.44M 0.02% 577
2020
Q1
$10.3M Buy
103,192
+2,864
+3% +$311K 0.01% 712
2019
Q4
$11.5M Sell
100,328
-5,004
-5% -$605K 0.01% 773
2019
Q3
$13.1M Sell
105,332
-10,689
-9% -$1.36M 0.01% 696
2019
Q2
$14M Buy
116,021
+831
+0.7% +$81.8K 0.02% 681
2019
Q1
$10.1M Sell
115,190
-5,490
-5% -$499K 0.01% 853
2018
Q4
$12.1M Buy
120,680
+2,966
+3% +$312K 0.02% 694
2018
Q3
$13.5M Sell
117,714
-3,051
-3% -$316K 0.01% 734
2018
Q2
$10.8M Buy
120,765
+81,218
+205% +$6.86M 0.01% 844
2018
Q1
$2.89M Sell
39,547
-770
-2% -$52.8K ﹤0.01% 1383
2017
Q4
$2.34M Buy
40,317
+827
+2% +$43.5K ﹤0.01% 1425
2017
Q3
$1.77M Sell
39,490
-416
-1% -$17.3K ﹤0.01% 1493
2017
Q2
$1.57M Buy
39,906
+488
+1% +$20K ﹤0.01% 1556
2017
Q1
$1.6M Buy
39,418
+4,792
+14% +$187K ﹤0.01% 1511
2016
Q4
$1.39M Sell
34,626
-60
-0.2% -$2.26K ﹤0.01% 1527
2016
Q3
$1.26M Buy
34,686
+122
+0.4% +$4.19K ﹤0.01% 1541
2016
Q2
$1M Buy
34,564
+232
+0.7% +$7.01K ﹤0.01% 1624
2016
Q1
$1.19M Buy
34,332
+781
+2% +$25.2K ﹤0.01% 1535
2015
Q4
$1.08M Buy
33,551
+362
+1% +$11.7K ﹤0.01% 1590
2015
Q3
$1.07M Buy
33,189
+1,006
+3% +$37.9K ﹤0.01% 1564
2015
Q2
$1.33M Sell
32,183
-1,876
-6% -$79.1K ﹤0.01% 1537
2015
Q1
$1.53M Buy
34,059
+1,034
+3% +$43.2K ﹤0.01% 1467
2014
Q4
$1.24M Sell
33,025
-688
-2% -$25.2K ﹤0.01% 1470
2014
Q3
$1.18M Buy
33,713
+1,102
+3% +$39.3K ﹤0.01% 1475
2014
Q2
$1.15M Sell
32,611
-5,762
-15% -$192K ﹤0.01% 1502
2014
Q1
$1.25M Buy
38,373
+73
+0.2% +$2.79K ﹤0.01% 1500
2013
Q4
$1.61M Sell
38,300
-330
-0.9% -$13.6K ﹤0.01% 1375
2013
Q3
$1.54M Sell
38,630
-1,285
-3% -$53.9K ﹤0.01% 1372
2013
Q2
$1.65M Buy
+39,915
New +$1.62M ﹤0.01% 1285

Other funds holding HAE

Manulife (Manufacturers Life Insurance)'s HAE Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Haemonetics (HAE) stake by 1.6% in Q2 2026, selling an estimated $44.8K and leaving 42,536 shares worth $3.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

Manulife (Manufacturers Life Insurance) first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $33.9M in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 42,536 shares of Haemonetics worth $3.19M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 697 Haemonetics shares in Q2 2026, an estimated $44.8K.
  • Haemonetics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1384 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Haemonetics position peaked at $33.9M in Q2 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.